Japan Tobacco Key Executives
This section highlights Japan Tobacco's key executives, including their titles and compensation details.
Find Contacts at Japan Tobacco
(Showing 0 of )
Japan Tobacco Earnings
This section highlights Japan Tobacco's earnings, including key dates, EPS, earnings reports, and earnings call transcripts.
Next Earnings Date
Last Earnings Results
Earnings Call Transcripts
| Transcript | Quarter | Year | Date | Estimated EPS | Actual EPS |
|---|---|---|---|---|---|
| Read Transcript | Q4 | 2024 | 2025-02-14 | N/A | N/A |
| Read Transcript | Q3 | 2024 | 2024-10-31 | $0.61 | $0.54 |
| Read Transcript | Q2 | 2024 | 2024-08-02 | $0.53 | $83.29 |
| Read Transcript | Q1 | 2024 | 2024-05-09 | $0.54 | $88.57 |
| Read Transcript | Q4 | 2023 | 2024-02-14 | N/A | N/A |
| Read Transcript | Q3 | 2023 | 2023-11-04 | N/A | N/A |
| Read Transcript | Q2 | 2023 | 2023-07-31 | N/A | N/A |
| Read Transcript | Q1 | 2023 | 2023-05-07 | N/A | N/A |
Japan Tobacco Inc., a tobacco company, manufactures and sells tobacco products, prescription drugs, and processed foods in Japan and internationally. The company operates through four segments: Domestic Tobacco, International Tobacco, Pharmaceutical, and Processed Food. It offers tobacco products, such as cigarettes, cigars, pipe tobacco, oral tobacco, waterpipe tobacco, kretek, and fine cut products under the Winston, Camel, MEVIUS, and LD brands. The company also provides reduced-risk products, including tobacco-infused vapor and heated tobacco products, E-Vapor products, etc. under the Ploom, Logic, Ploom TECH, Ploom TECH+, and Ploom S brands. In addition, it researches and develops, manufactures, and sells prescription drugs for the therapeutic areas, such as cardiovascular, renal and metabolism, immunology, and neuroscience. Further, the company provides staple food products, such as frozen noodles and okonomiyaki, and frozen and packed cooked rice; ambient processed foods; bakery products; and seasonings, including yeast extracts and oyster sauce. Japan Tobacco Inc. was founded in 1898 and is headquartered in Tokyo, Japan.
$29.00
Stock Price
$51.49B
Market Cap
-
Employees
Tokyo, None
Location
Financial Statements
Access annual & quarterly financial statements for Japan Tobacco, including income statements, balance sheets, and cash flow statements..
Annual Income Statement
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 |
|---|---|---|---|---|---|
| Revenue | $3.15T | $2.84T | $2.66T | $2.32T | $2.09T |
| Cost of Revenue | $1.41T | $1.23T | $1.09T | $956.86B | $898.00B |
| Gross Profit | $1.74T | $1.62T | $1.57T | $1.37T | $1.19T |
| Gross Profit Ratio | 55.32% | 56.85% | 58.95% | 58.84% | 57.09% |
| Research and Development Expenses | $- | $- | $70.81B | $65.02B | $60.85B |
| General and Administrative Expenses | $1.46T | $981.05B | $941.54B | $888.57B | $784.47B |
| Selling and Marketing Expenses | $- | $- | $233.37B | $204.84B | $177.02B |
| Selling General and Administrative Expenses | $1.46T | $981.05B | $941.54B | $888.57B | $784.47B |
| Other Expenses | $-44.09B | $-38.36B | $- | $- | $- |
| Operating Expenses | $1.42T | $942.69B | $921.28B | $872.95B | $729.55B |
| Cost and Expenses | $2.83T | $2.17T | $2.01T | $1.83T | $1.63T |
| Interest Income | $69.50B | $44.41B | $31.15B | $19.01B | $12.35B |
| Interest Expense | $159.20B | $95.22B | $91.27B | $45.65B | $61.34B |
| Depreciation and Amortization | $179.84B | $179.65B | $199.37B | $187.00B | $179.29B |
| EBITDA | $572.80B | $824.78B | $836.31B | $673.86B | $661.06B |
| EBITDA Ratio | 18.19% | 29.03% | 31.47% | 28.99% | 31.59% |
| Operating Income | $323.46B | $672.41B | $653.58B | $499.02B | $469.05B |
| Operating Income Ratio | 10.27% | 23.67% | 24.59% | 21.46% | 22.42% |
| Total Other Income Expenses Net | $-89.69B | $-50.81B | $-60.12B | $-26.63B | $-48.99B |
| Income Before Tax | $233.77B | $621.60B | $593.45B | $472.39B | $420.06B |
| Income Before Tax Ratio | 7.42% | 21.88% | 22.33% | 20.32% | 20.07% |
| Income Tax Expense | $51.17B | $136.29B | $149.28B | $132.21B | $108.03B |
| Net Income | $179.24B | $482.29B | $442.72B | $338.49B | $310.25B |
| Net Income Ratio | 5.69% | 16.98% | 16.66% | 14.56% | 14.83% |
| EPS | $100.95 | $271.63 | $249.45 | $190.76 | $174.88 |
| EPS Diluted | $100.94 | $271.63 | $249.36 | $190.68 | $174.80 |
| Weighted Average Shares Outstanding | 1.78B | 1.78B | 1.77B | 1.77B | 1.77B |
| Weighted Average Shares Outstanding Diluted | 1.78B | 1.78B | 1.78B | 1.78B | 1.77B |
| SEC Filing | Source | Source | Source | Source | Source |
| Breakdown | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | June 30, 2023 | March 31, 2023 | December 31, 2022 | September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | June 30, 2020 | March 31, 2020 | December 31, 2019 | September 30, 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $829.56B | $740.33B | $684.06B | $764.21B | $727.53B | $665.28B | $649.28B | $741.72B | $685.32B | $581.50B | $558.76B | $621.54B | $597.17B | $547.37B | $500.46B | $561.88B | $510.60B | $519.62B | $541.88B | $575.20B |
| Cost of Revenue | $362.18B | $320.10B | $372.83B | $315.56B | $301.48B | $262.33B | $284.51B | $298.61B | $276.59B | $231.28B | $248.21B | $253.22B | $238.82B | $216.60B | $226.96B | $234.59B | $215.32B | $221.13B | $252.53B | $241.35B |
| Gross Profit | $467.38B | $420.23B | $311.23B | $448.64B | $426.06B | $402.95B | $364.78B | $443.11B | $408.73B | $350.23B | $310.55B | $368.31B | $358.35B | $330.76B | $273.50B | $327.29B | $295.28B | $298.49B | $289.35B | $333.85B |
| Gross Profit Ratio | 56.34% | 56.76% | 45.50% | 58.71% | 58.56% | 60.57% | 56.18% | 59.74% | 59.64% | 60.23% | 55.58% | 59.26% | 60.01% | 60.43% | 54.65% | 58.25% | 57.83% | 57.44% | 53.40% | 58.04% |
| Research and Development Expenses | $- | $17.27B | $22.05B | $18.16B | $17.82B | $17.07B | $21.59B | $16.63B | $17.05B | $15.54B | $18.26B | $15.18B | $16.88B | $14.70B | $60.85B | $- | $- | $- | $64.08B | $- |
| General and Administrative Expenses | $261.86B | $212.86B | $305.65B | $247.35B | $226.77B | $201.28B | $301.68B | $252.37B | $212.20B | $175.29B | $298.04B | $216.53B | $200.40B | $173.60B | $245.31B | $191.77B | $174.21B | $173.19B | $252.26B | $211.54B |
| Selling and Marketing Expenses | $- | $- | $-59.99B | $- | $- | $- | $233.37B | $- | $- | $- | $204.84B | $- | $- | $- | $177.02B | $- | $- | $- | $191.03B | $- |
| Selling General and Administrative Expenses | $261.86B | $212.86B | $245.67B | $247.35B | $226.77B | $201.28B | $301.68B | $252.37B | $212.20B | $175.29B | $298.04B | $216.53B | $200.40B | $173.60B | $245.31B | $191.77B | $174.21B | $173.19B | $252.26B | $211.54B |
| Other Expenses | $-11.32B | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Operating Expenses | $250.54B | $206.49B | $267.72B | $233.61B | $221.16B | $197.84B | $292.29B | $249.38B | $206.94B | $172.67B | $292.68B | $211.59B | $197.49B | $171.19B | $195.63B | $190.52B | $173.24B | $170.16B | $228.76B | $205.81B |
| Cost and Expenses | $612.72B | $526.59B | $640.55B | $549.17B | $522.64B | $460.17B | $576.79B | $547.99B | $483.53B | $403.95B | $540.89B | $464.81B | $436.31B | $387.80B | $422.60B | $425.11B | $388.56B | $391.29B | $481.29B | $447.16B |
| Interest Income | $16.61B | $14.88B | $13.35B | $12.66B | $9.51B | $7.48B | $13.39B | $7.87B | $4.74B | $5.15B | $3.20B | $8.90B | $3.38B | $3.54B | $6.52B | $2.09B | $2.14B | $1.60B | $2.47B | $1.82B |
| Interest Expense | $35.65B | $29.43B | $7.07B | $18.17B | $26.38B | $30.74B | $29.77B | $29.63B | $23.05B | $8.82B | $12.96B | $17.78B | $7.58B | $7.33B | $10.89B | $20.69B | $14.31B | $15.45B | $10.56B | $10.15B |
| Depreciation and Amortization | $44.16B | $43.97B | $49.41B | $43.91B | $44.10B | $42.23B | $47.96B | $54.65B | $50.67B | $46.37B | $47.30B | $48.03B | $46.91B | $44.79B | $32.60B | $44.25B | $44.43B | $46.47B | $36.48B | $44.62B |
| EBITDA | $277.61B | $257.71B | $69.50B | $258.94B | $248.99B | $247.34B | $111.54B | $248.38B | $252.47B | $223.93B | $56.97B | $204.75B | $207.77B | $204.38B | $84.22B | $181.02B | $166.47B | $174.80B | $68.58B | $172.66B |
| EBITDA Ratio | 33.46% | 34.81% | 10.16% | 33.88% | 34.22% | 37.18% | 17.18% | 33.49% | 36.84% | 38.51% | 10.20% | 32.94% | 34.79% | 37.34% | 16.83% | 32.22% | 32.60% | 33.64% | 12.66% | 30.02% |
| Operating Income | $216.84B | $215.82B | $43.51B | $218.29B | $207.15B | $206.40B | $74.23B | $196.37B | $204.60B | $178.37B | $18.32B | $158.61B | $161.96B | $160.13B | $78.87B | $138.19B | $123.03B | $128.95B | $61.76B | $129.27B |
| Operating Income Ratio | 26.14% | 29.15% | 6.36% | 28.56% | 28.47% | 31.03% | 11.43% | 26.47% | 29.86% | 30.67% | 3.28% | 25.52% | 27.12% | 29.25% | 15.76% | 24.59% | 24.10% | 24.82% | 11.40% | 22.47% |
| Total Other Income Expenses Net | $-19.04B | $-14.55B | $-5.17B | $-5.51B | $-16.87B | $-23.26B | $-16.38B | $-21.76B | $-18.32B | $-3.67B | $-9.76B | $-8.89B | $-4.20B | $-3.79B | $-4.37B | $-18.59B | $-10.21B | $-13.85B | $-8.09B | $-8.32B |
| Income Before Tax | $197.81B | $201.27B | $35.39B | $212.78B | $190.28B | $183.15B | $57.85B | $174.61B | $186.28B | $174.70B | $8.57B | $149.73B | $157.75B | $156.34B | $74.50B | $119.60B | $110.86B | $115.10B | $53.67B | $120.95B |
| Income Before Tax Ratio | 23.84% | 27.19% | 5.17% | 27.84% | 26.15% | 27.53% | 8.91% | 23.54% | 27.18% | 30.04% | 1.53% | 24.09% | 26.42% | 28.56% | 14.89% | 21.29% | 21.71% | 22.15% | 9.90% | 21.03% |
| Income Tax Expense | $48.45B | $43.50B | $-5.38B | $56.71B | $47.05B | $37.92B | $17.61B | $35.69B | $45.88B | $50.10B | $8.67B | $35.38B | $45.85B | $42.30B | $22.10B | $33.33B | $24.39B | $28.22B | $20.82B | $30.60B |
| Net Income | $147.91B | $157.26B | $40.28B | $155.00B | $142.33B | $144.68B | $38.91B | $139.74B | $139.95B | $124.11B | $-323.00M | $113.62B | $111.40B | $113.79B | $52.31B | $85.45B | $86.12B | $86.37B | $32.04B | $89.70B |
| Net Income Ratio | 17.83% | 21.24% | 5.89% | 20.28% | 19.56% | 21.75% | 5.99% | 18.84% | 20.42% | 21.34% | -0.06% | 18.28% | 18.66% | 20.79% | 10.45% | 15.21% | 16.87% | 16.62% | 5.91% | 15.59% |
| EPS | $83.29 | $88.58 | $22.69 | $87.31 | $80.18 | $81.52 | $21.92 | $78.74 | $78.86 | $69.94 | $-0.19 | $64.03 | $62.78 | $64.13 | $29.47 | $48.16 | $48.54 | $48.69 | $18.05 | $50.57 |
| EPS Diluted | $83.29 | $88.57 | $22.68 | $87.29 | $80.16 | $81.49 | $21.91 | $78.71 | $78.83 | $69.91 | $-0.18 | $64.00 | $62.76 | $64.10 | $29.47 | $48.14 | $48.52 | $48.67 | $18.05 | $50.54 |
| Weighted Average Shares Outstanding | 1.78B | 1.78B | 1.78B | 1.78B | 1.78B | 1.77B | 1.77B | 1.77B | 1.77B | 1.77B | 1.73B | 1.77B | 1.77B | 1.77B | 1.77B | 1.77B | 1.77B | 1.77B | 1.77B | 1.77B |
| Weighted Average Shares Outstanding Diluted | 1.78B | 1.78B | 1.78B | 1.78B | 1.78B | 1.78B | 1.78B | 1.78B | 1.78B | 1.78B | 1.77B | 1.78B | 1.78B | 1.78B | 1.77B | 1.78B | 1.77B | 1.77B | 1.77B | 1.77B |
| SEC Filing | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source |
Annual Balance Sheet
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 |
|---|---|---|---|---|---|
| Cash and Cash Equivalents | $1.08T | $1.04T | $866.88B | $721.73B | $538.84B |
| Short Term Investments | $120.21B | $58.63B | $37.68B | $17.25B | $18.83B |
| Cash and Short Term Investments | $1.20T | $1.04T | $904.56B | $738.99B | $557.67B |
| Net Receivables | $- | $535.30B | $477.24B | $456.59B | $402.80B |
| Inventory | $957.28B | $832.61B | $691.91B | $563.18B | $539.76B |
| Other Current Assets | $1.42T | $851.44B | $687.56B | $579.79B | $503.69B |
| Total Current Assets | $3.58T | $3.26T | $2.72T | $2.32T | $2.00T |
| Property Plant Equipment Net | $907.70B | $821.50B | $775.96B | $755.84B | $759.29B |
| Goodwill | $2.91T | $2.62T | $2.45T | $2.06T | $1.91T |
| Intangible Assets | $486.46B | $206.98B | $246.44B | $307.15B | $363.60B |
| Goodwill and Intangible Assets | $3.40T | $2.82T | $2.69T | $2.37T | $2.27T |
| Long Term Investments | $82.15B | $288.24B | $159.63B | $133.12B | $128.54B |
| Tax Assets | $183.59B | $- | $91.43B | $120.42B | $122.53B |
| Other Non-Current Assets | $219.00B | $89.38B | $104.96B | $75.42B | $94.10B |
| Total Non-Current Assets | $4.79T | $4.02T | $3.82T | $3.45T | $3.38T |
| Other Assets | $- | $- | $- | $- | $-1.00M |
| Total Assets | $8.37T | $7.28T | $6.55T | $5.77T | $5.38T |
| Account Payables | $659.51B | $592.80B | $540.09B | $555.78B | $233.72B |
| Short Term Debt | $178.67B | $233.33B | $137.31B | $142.90B | $141.47B |
| Tax Payables | $24.62B | $29.65B | $37.47B | $30.79B | $46.46B |
| Deferred Revenue | $- | $- | $104.17B | $83.99B | $93.47B |
| Other Current Liabilities | $1.29T | $1.07T | $743.59B | $686.86B | $902.14B |
| Total Current Liabilities | $2.15T | $1.93T | $1.56T | $1.50T | $1.32T |
| Long Term Debt | $1.55T | $908.93B | $820.97B | $775.72B | $866.69B |
| Deferred Revenue Non-Current | $- | $- | $312.34B | $362.93B | $413.25B |
| Deferred Tax Liabilities Non-Current | $124.45B | $40.59B | $40.06B | $69.96B | $64.45B |
| Other Non-Current Liabilities | $700.82B | $492.82B | $195.25B | $249.15B | $178.15B |
| Total Non-Current Liabilities | $2.37T | $1.44T | $1.37T | $1.39T | $1.46T |
| Other Liabilities | $- | $- | $- | $- | $- |
| Total Liabilities | $4.52T | $3.37T | $2.93T | $2.89T | $2.78T |
| Preferred Stock | $- | $- | $- | $400.09B | $605.78B |
| Common Stock | $100.00B | $100.00B | $100.00B | $100.00B | $100.00B |
| Retained Earnings | $3.04T | $3.19T | $3.09T | $2.86T | $2.78T |
| Accumulated Other Comprehensive Income Loss | $- | $- | $104.31B | $-400.09B | $-605.78B |
| Other Total Stockholders Equity | $629.72B | $537.83B | $246.22B | $-554.67B | $-966.66B |
| Total Stockholders Equity | $3.77T | $3.83T | $3.54T | $2.81T | $2.52T |
| Total Equity | $3.85T | $3.91T | $3.62T | $2.89T | $2.60T |
| Total Liabilities and Stockholders Equity | $8.37T | $7.28T | $6.55T | $5.77T | $5.38T |
| Minority Interest | $82.10B | $82.34B | $76.33B | $76.82B | $76.66B |
| Total Liabilities and Total Equity | $8.37T | $7.28T | $6.55T | $5.77T | $5.38T |
| Total Investments | $202.36B | $222.38B | $197.31B | $150.38B | $147.37B |
| Total Debt | $1.73T | $1.14T | $958.31B | $918.62B | $958.88B |
| Net Debt | $642.22B | $102.05B | $91.43B | $196.89B | $420.04B |
Balance Sheet Charts
| Breakdown | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | June 30, 2023 | March 31, 2023 | December 31, 2022 | September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | June 30, 2020 | March 31, 2020 | December 31, 2019 | September 30, 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and Cash Equivalents | $1.09T | $766.95B | $1.04T | $869.04B | $827.22B | $665.15B | $866.88B | $778.46B | $748.70B | $655.26B | $721.73B | $630.65B | $480.71B | $424.31B | $538.84B | $458.13B | $407.74B | $301.06B | $357.16B | $181.68B |
| Short Term Investments | $24.48B | $50.46B | $58.63B | $77.97B | $83.32B | $40.23B | $37.68B | $58.78B | $37.58B | $35.23B | $17.25B | $18.26B | $20.58B | $21.26B | $18.83B | $25.94B | $28.17B | $40.85B | $21.94B | $32.60B |
| Cash and Short Term Investments | $1.11T | $817.41B | $1.04T | $947.02B | $910.54B | $705.38B | $904.56B | $837.24B | $786.28B | $690.49B | $738.99B | $648.92B | $501.29B | $445.57B | $557.67B | $458.13B | $435.91B | $341.91B | $379.10B | $214.27B |
| Net Receivables | $657.92B | $571.26B | $535.30B | $570.07B | $561.81B | $473.83B | $477.24B | $548.03B | $553.54B | $445.37B | $456.59B | $486.14B | $464.58B | $431.28B | $402.80B | $433.56B | $445.35B | $407.04B | $430.40B | $470.88B |
| Inventory | $941.57B | $875.47B | $832.61B | $826.95B | $772.30B | $705.16B | $691.91B | $685.23B | $654.67B | $583.43B | $563.18B | $540.21B | $549.82B | $553.04B | $539.76B | $600.12B | $653.71B | $622.12B | $677.59B | $642.35B |
| Other Current Assets | $749.59B | $771.13B | $851.44B | $717.03B | $742.20B | $649.58B | $687.56B | $614.97B | $630.92B | $561.48B | $579.79B | $513.26B | $564.10B | $522.22B | $503.69B | $420.28B | $403.31B | $432.59B | $532.48B | $427.20B |
| Total Current Assets | $3.46T | $2.98T | $3.26T | $2.98T | $2.90T | $2.49T | $2.72T | $2.63T | $2.59T | $2.25T | $2.32T | $2.17T | $2.06T | $1.93T | $2.00T | $1.91T | $1.91T | $1.76T | $1.93T | $1.72T |
| Property Plant Equipment Net | $890.15B | $846.26B | $821.50B | $812.78B | $810.15B | $775.82B | $775.96B | $802.18B | $822.04B | $760.14B | $755.84B | $758.06B | $763.18B | $767.18B | $759.29B | $753.25B | $780.73B | $782.18B | $803.24B | $790.96B |
| Goodwill | $2.93T | $2.73T | $2.62T | $2.71T | $2.65T | $2.48T | $2.45T | $2.62T | $2.54T | $2.10T | $2.06T | $2.04T | $2.03T | $1.99T | $1.91T | $1.87T | $1.91T | $1.89T | $2.00T | $1.94T |
| Intangible Assets | $191.40B | $193.66B | $206.98B | $228.13B | $237.29B | $236.53B | $246.44B | $276.20B | $297.56B | $297.00B | $307.15B | $324.59B | $345.89B | $363.38B | $363.60B | $376.52B | $396.89B | $410.87B | $440.43B | $443.75B |
| Goodwill and Intangible Assets | $3.12T | $2.93T | $2.82T | $2.94T | $2.89T | $2.72T | $2.69T | $2.90T | $2.84T | $2.40T | $2.37T | $2.36T | $2.37T | $2.35T | $2.27T | $1.87T | $2.30T | $2.30T | $2.44T | $2.39T |
| Long Term Investments | $300.31B | $169.79B | $222.38B | $134.38B | $129.08B | $158.85B | $159.63B | $152.66B | $164.52B | $117.31B | $133.12B | $130.92B | $127.09B | $134.16B | $128.54B | $-1.80T | $115.67B | $103.94B | $140.53B | $141.75B |
| Tax Assets | $- | $95.95B | $89.38B | $80.24B | $80.59B | $91.14B | $91.43B | $116.17B | $117.36B | $125.59B | $120.42B | $109.93B | $113.27B | $112.97B | $122.53B | $122.56B | $128.32B | $132.47B | $134.70B | $121.14B |
| Other Non-Current Assets | $98.09B | $136.84B | $65.86B | $154.79B | $159.41B | $109.68B | $104.96B | $130.99B | $115.36B | $99.00B | $75.42B | $98.94B | $102.09B | $101.79B | $94.10B | $2.39T | $108.22B | $122.04B | $105.91B | $105.01B |
| Total Non-Current Assets | $4.41T | $4.17T | $4.02T | $4.12T | $4.07T | $3.85T | $3.82T | $4.10T | $4.06T | $3.50T | $3.45T | $3.46T | $3.48T | $3.47T | $3.38T | $3.33T | $3.44T | $3.44T | $3.63T | $3.55T |
| Other Assets | $- | $1.00M | $- | $- | $- | $- | $- | $-1.00M | $- | $-1.00M | $- | $- | $- | $- | $-1.00M | $- | $- | $1.00M | $1.00M | $1.00M |
| Total Assets | $7.87T | $7.16T | $7.28T | $7.10T | $6.97T | $6.35T | $6.55T | $6.73T | $6.65T | $5.75T | $5.77T | $5.63T | $5.54T | $5.40T | $5.38T | $5.24T | $5.35T | $5.20T | $5.55T | $5.27T |
| Account Payables | $524.78B | $523.22B | $592.80B | $486.27B | $481.86B | $473.30B | $540.09B | $455.66B | $462.42B | $483.80B | $555.78B | $426.12B | $388.67B | $382.83B | $233.72B | $374.64B | $357.73B | $351.40B | $229.91B | $348.24B |
| Short Term Debt | $76.55B | $80.32B | $233.33B | $59.86B | $136.25B | $142.11B | $137.31B | $167.86B | $161.07B | $162.51B | $142.90B | $167.14B | $78.82B | $158.32B | $158.72B | $346.03B | $383.01B | $290.44B | $298.26B | $423.24B |
| Tax Payables | $35.42B | $37.46B | $29.65B | $77.04B | $69.69B | $71.35B | $37.47B | $75.69B | $72.47B | $49.97B | $30.79B | $39.71B | $43.38B | $29.78B | $46.46B | $- | $53.80B | $58.57B | $69.54B | $41.14B |
| Deferred Revenue | $- | $99.84B | $29.65B | $136.15B | $137.29B | $132.71B | $104.17B | $157.79B | $162.01B | $120.33B | $83.99B | $89.38B | $100.08B | $82.56B | $93.47B | $-346.03B | $96.08B | $98.44B | $107.97B | $70.69B |
| Other Current Liabilities | $1.10T | $888.98B | $1.07T | $804.01B | $703.81B | $604.78B | $743.59B | $618.40B | $592.80B | $561.69B | $686.86B | $615.58B | $590.15B | $582.05B | $884.88B | $703.88B | $531.57B | $521.25B | $904.04B | $509.26B |
| Total Current Liabilities | $1.73T | $1.63T | $1.93T | $1.56T | $1.53T | $1.42T | $1.56T | $1.48T | $1.45T | $1.38T | $1.50T | $1.34T | $1.20T | $1.24T | $1.32T | $1.42T | $1.42T | $1.32T | $1.50T | $1.39T |
| Long Term Debt | $1.08T | $939.27B | $908.93B | $954.13B | $946.75B | $832.85B | $820.97B | $769.74B | $841.31B | $799.95B | $775.72B | $799.89B | $848.15B | $840.98B | $866.69B | $689.44B | $697.69B | $783.12B | $729.95B | $638.38B |
| Deferred Revenue Non-Current | $- | $364.23B | $37.79B | $344.74B | $334.37B | $308.57B | $312.34B | $323.85B | $329.40B | $341.90B | $362.93B | $380.53B | $391.85B | $388.18B | $413.25B | $- | $373.43B | $374.40B | $381.14B | $361.38B |
| Deferred Tax Liabilities Non-Current | $- | $39.39B | $40.59B | $53.00B | $41.93B | $38.69B | $40.06B | $79.56B | $80.39B | $71.31B | $69.96B | $73.94B | $75.89B | $69.61B | $64.45B | $- | $72.57B | $72.60B | $80.43B | $80.50B |
| Other Non-Current Liabilities | $533.19B | $153.23B | $495.62B | $237.67B | $214.62B | $155.96B | $195.25B | $208.88B | $272.74B | $244.06B | $249.15B | $244.97B | $234.94B | $228.22B | $178.15B | $616.55B | $155.63B | $222.52B | $196.61B | $243.06B |
| Total Non-Current Liabilities | $1.61T | $1.46T | $1.44T | $1.54T | $1.50T | $1.34T | $1.37T | $1.38T | $1.44T | $1.39T | $1.39T | $1.43T | $1.47T | $1.46T | $1.46T | $1.31T | $1.30T | $1.38T | $1.31T | $1.24T |
| Other Liabilities | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $2.51T | $- | $- | $- | $- |
| Total Liabilities | $3.34T | $3.09T | $3.37T | $3.10T | $3.02T | $2.76T | $2.93T | $2.86T | $2.89T | $2.76T | $2.89T | $2.76T | $2.68T | $2.69T | $2.78T | $5.24T | $2.72T | $2.70T | $2.81T | $2.64T |
| Preferred Stock | $- | $- | $- | $- | $- | $- | $- | $- | $- | $314.67B | $400.09B | $437.56B | $443.15B | $- | $605.78B | $546.22B | $586.90B | $622.46B | $431.74B | $497.58B |
| Common Stock | $100.00B | $100.00B | $100.00B | $100.00B | $100.00B | $100.00B | $100.00B | $100.00B | $100.00B | $100.00B | $100.00B | $100.00B | $100.00B | $100.00B | $100.00B | $100.00B | $100.00B | $100.00B | $100.00B | $100.00B |
| Retained Earnings | $3.34T | $3.17T | $3.19T | $3.17T | $3.18T | $3.03T | $3.09T | $3.04T | $3.03T | $2.87T | $2.86T | $2.88T | $2.88T | $2.77T | $2.78T | $2.74T | $2.79T | $2.70T | $2.75T | $2.71T |
| Accumulated Other Comprehensive Income Loss | $- | $470.12B | $290.55B | $406.69B | $343.72B | $126.69B | $104.31B | $400.17B | $297.27B | $-314.67B | $-400.09B | $-437.56B | $-443.15B | $344.94B | $-605.78B | $-646.22B | $-586.90B | $-622.46B | $-431.74B | $-497.58B |
| Other Total Stockholders Equity | $1.00T | $247.32B | $247.28B | $247.28B | $246.68B | $246.36B | $246.22B | $246.21B | $246.21B | $-383.74B | $-554.67B | $-629.64B | $-640.81B | $-244.04B | $-966.66B | $-947.55B | $-928.92B | $-1.00T | $-619.55B | $-751.25B |
| Total Stockholders Equity | $4.44T | $3.99T | $3.83T | $3.92T | $3.87T | $3.51T | $3.54T | $3.79T | $3.68T | $2.91T | $2.81T | $2.79T | $2.79T | $2.63T | $2.52T | $2.43T | $2.54T | $2.42T | $2.66T | $2.55T |
| Total Equity | $4.53T | $4.07T | $3.91T | $4.00T | $3.95T | $3.59T | $3.62T | $3.87T | $3.75T | $2.98T | $2.89T | $2.87T | $2.86T | $2.71T | $2.60T | $2.51T | $2.62T | $2.50T | $2.74T | $2.63T |
| Total Liabilities and Stockholders Equity | $7.87T | $7.16T | $7.28T | $7.10T | $6.97T | $6.35T | $6.55T | $6.73T | $6.65T | $5.75T | $5.77T | $5.63T | $5.54T | $5.40T | $5.38T | $7.68T | $5.35T | $5.20T | $5.55T | $5.27T |
| Minority Interest | $84.08B | $82.97B | $82.34B | $82.57B | $82.08B | $78.96B | $76.33B | $76.52B | $77.49B | $77.32B | $76.82B | $76.50B | $76.75B | $76.66B | $76.66B | $79.36B | $79.31B | $79.14B | $80.92B | $80.28B |
| Total Liabilities and Total Equity | $7.87T | $7.16T | $7.28T | $7.10T | $6.97T | $6.35T | $6.55T | $6.73T | $6.65T | $5.75T | $5.77T | $5.63T | $5.54T | $5.40T | $5.38T | $7.68T | $5.35T | $5.20T | $5.55T | $5.27T |
| Total Investments | $212.96B | $220.25B | $222.38B | $212.36B | $212.40B | $199.07B | $197.31B | $211.44B | $202.10B | $152.54B | $150.38B | $149.18B | $147.67B | $155.42B | $147.37B | $233.35B | $143.84B | $144.79B | $162.47B | $174.35B |
| Total Debt | $1.15T | $1.02T | $1.20T | $1.01T | $1.08T | $974.99B | $958.31B | $940.02B | $1.00T | $962.47B | $918.62B | $967.02B | $926.97B | $999.30B | $958.88B | $689.44B | $1.08T | $1.07T | $974.50B | $1.06T |
| Net Debt | $64.64B | $252.64B | $161.64B | $144.94B | $255.78B | $309.84B | $91.43B | $161.56B | $253.68B | $307.21B | $196.89B | $336.37B | $446.27B | $575.00B | $420.04B | $231.31B | $673.78B | $772.50B | $617.34B | $879.95B |
Annual Cash Flow
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 |
|---|---|---|---|---|---|
| Net Income | $233.77B | $621.60B | $593.45B | $472.39B | $420.06B |
| Depreciation and Amortization | $179.84B | $179.65B | $199.65B | $187.06B | $179.65B |
| Deferred Income Tax | $- | $- | $- | $- | $-593.00M |
| Stock Based Compensation | $- | $- | $- | $- | $593.00M |
| Change in Working Capital | $300.38B | $-115.90B | $-103.04B | $56.68B | $66.66B |
| Accounts Receivables | $45.77B | $-30.17B | $26.57B | $-29.89B | $21.55B |
| Inventory | $-96.57B | $-136.23B | $-93.91B | $9.77B | $748.00M |
| Accounts Payables | $- | $41.00B | $-38.25B | $111.91B | $39.29B |
| Other Working Capital | $351.18B | $9.50B | $2.55B | $-35.11B | $5.07B |
| Other Non Cash Items | $-83.97B | $-118.34B | $-206.26B | $-117.22B | $-146.55B |
| Net Cash Provided by Operating Activities | $630.01B | $567.01B | $483.80B | $598.91B | $519.83B |
| Investments in Property Plant and Equipment | $-127.77B | $-94.86B | $-99.41B | $-102.92B | $-108.62B |
| Acquisitions Net | $-265.25B | $- | $3.03B | $2.56B | $16.27B |
| Purchases of Investments | $-113.78B | $-113.01B | $-37.76B | $-29.24B | $-40.48B |
| Sales Maturities of Investments | $81.32B | $84.36B | $19.81B | $25.36B | $50.14B |
| Other Investing Activities | $-14.29B | $-2.62B | $12.51B | $6.74B | $88.05B |
| Net Cash Used for Investing Activities | $-439.77B | $-126.13B | $-101.82B | $-97.50B | $5.35B |
| Debt Repayment | $283.63B | $-20.42B | $-2.15B | $-101.72B | $-2.11B |
| Common Stock Issued | $- | $- | $- | $- | $- |
| Common Stock Repurchased | $-2.00M | $-1.00M | $-1.00M | $-1.00M | $-1.00M |
| Dividends Paid | $-349.64B | $-367.33B | $-266.18B | $-251.94B | $-273.13B |
| Other Financing Activities | $-28.89B | $117.25B | $-37.85B | $522.00M | $-22.16B |
| Net Cash Used Provided by Financing Activities | $-94.91B | $-270.50B | $-306.18B | $-353.14B | $-297.40B |
| Effect of Forex Changes on Cash | $-50.98B | $2.94B | $69.35B | $34.62B | $-46.10B |
| Net Change in Cash | $44.36B | $173.32B | $145.15B | $182.89B | $181.69B |
| Cash at End of Period | $1.08T | $1.04T | $866.88B | $721.73B | $538.84B |
| Cash at Beginning of Period | $1.04T | $866.88B | $721.73B | $538.84B | $357.16B |
| Operating Cash Flow | $630.01B | $567.01B | $483.80B | $598.91B | $519.83B |
| Capital Expenditure | $-150.37B | $-121.21B | $-99.41B | $-102.92B | $-108.62B |
| Free Cash Flow | $479.64B | $449.75B | $384.39B | $495.99B | $411.21B |
Cash Flow Charts
| Breakdown | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | June 30, 2023 | March 31, 2023 | December 31, 2022 | September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | June 30, 2020 | March 31, 2020 | December 31, 2019 | September 30, 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $147.91B | $201.27B | $40.28B | $212.78B | $190.28B | $183.15B | $57.85B | $174.61B | $186.29B | $174.70B | $8.57B | $149.73B | $157.75B | $156.34B | $74.50B | $119.60B | $110.86B | $115.10B | $53.67B | $120.95B |
| Depreciation and Amortization | $44.16B | $43.97B | $49.41B | $43.91B | $44.10B | $42.23B | $47.96B | $54.65B | $50.67B | $46.37B | $47.31B | $48.03B | $46.91B | $44.81B | $44.50B | $44.25B | $44.43B | $46.47B | $47.98B | $44.62B |
| Deferred Income Tax | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Stock Based Compensation | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $593.00M | $- | $- | $- | $291.00M | $- |
| Change in Working Capital | $-5.57B | $-103.27B | $45.54B | $65.07B | $-34.64B | $-140.34B | $138.06B | $34.17B | $-132.24B | $-143.04B | $132.90B | $93.39B | $-28.60B | $-141.00B | $68.00B | $140.35B | $-11.82B | $-129.86B | $194.77B | $-82.42B |
| Accounts Receivables | $-50.72B | $-19.61B | $35.45B | $-11.07B | $-60.64B | $6.10B | $42.70B | $1.10B | $-40.13B | $22.90B | $27.98B | $-20.25B | $-30.53B | $-7.09B | $29.66B | $15.48B | $-35.18B | $11.59B | $41.51B | $-13.19B |
| Inventory | $-29.38B | $-10.87B | $-38.76B | $-49.11B | $-33.99B | $-14.37B | $-56.71B | $-23.95B | $-10.98B | $-2.26B | $-20.05B | $11.81B | $9.01B | $8.99B | $-34.31B | $31.72B | $-30.28B | $33.61B | $-25.57B | $-9.04B |
| Accounts Payables | $-24.39B | $-80.99B | $104.77B | $2.81B | $-3.80B | $-62.78B | $93.46B | $3.65B | $-57.94B | $-77.42B | $128.89B | $34.17B | $9.85B | $-61.01B | $- | $- | $- | $- | $- | $- |
| Other Working Capital | $98.93B | $-28.44B | $-55.91B | $122.44B | $63.79B | $-69.29B | $58.61B | $53.38B | $-23.19B | $-140.77B | $152.94B | $81.58B | $-37.61B | $-150.00B | $102.30B | $108.62B | $18.45B | $-163.47B | $220.34B | $-73.38B |
| Other Non Cash Items | $11.88B | $-43.39B | $-58.65B | $-38.19B | $-48.55B | $-29.37B | $-103.70B | $-30.00B | $-33.52B | $-39.05B | $-18.80B | $-37.09B | $-13.54B | $-47.79B | $-65.33B | $-32.67B | $-14.89B | $-33.66B | $-13.78B | $-47.31B |
| Net Cash Provided by Operating Activities | $198.37B | $61.83B | $76.58B | $283.57B | $151.20B | $55.66B | $140.18B | $233.44B | $71.20B | $38.98B | $169.98B | $254.06B | $162.52B | $12.35B | $121.67B | $271.52B | $128.58B | $-1.94B | $282.64B | $35.83B |
| Investments in Property Plant and Equipment | $-29.88B | $-28.85B | $-42.41B | $-27.87B | $-21.91B | $-29.03B | $-34.69B | $-24.10B | $-21.00B | $-19.62B | $-30.40B | $-25.63B | $-24.77B | $-22.12B | $-33.17B | $-26.14B | $-20.01B | $-29.29B | $-41.72B | $-31.35B |
| Acquisitions Net | $- | $-7.00M | $-8.00M | $396.00M | $-2.16B | $973.00M | $2.98B | $-4.17B | $43.00M | $-2.88B | $50.00M | $961.00M | $1.40B | $1.11B | $-125.00M | $-1.00B | $-4.34B | $17.40B | $-6.59B | $-4.83B |
| Purchases of Investments | $-8.74B | $-10.17B | $-36.37B | $-4.71B | $-48.25B | $-23.68B | $-9.59B | $-7.04B | $-9.16B | $-11.96B | $-8.76B | $-6.30B | $-8.53B | $-5.64B | $-8.64B | $-4.64B | $-12.86B | $-14.35B | $-12.29B | $-12.65B |
| Sales Maturities of Investments | $39.63B | $9.65B | $56.30B | $18.70B | $4.71B | $8.53B | $4.23B | $357.00M | $6.05B | $9.17B | $7.98B | $7.11B | $7.05B | $3.21B | $8.29B | $13.13B | $12.29B | $16.42B | $49.32B | $4.16B |
| Other Investing Activities | $-2.04B | $-375.00M | $393.00M | $12.09B | $6.66B | $1.50B | $5.22B | $3.81B | $7.96B | $2.58B | $-1.31B | $-1.84B | $-4.52B | $-2.16B | $77.06B | $12.00M | $-4.13B | $-8.20B | $3.69B | $-2.98B |
| Net Cash Used for Investing Activities | $-1.03B | $-27.67B | $-22.10B | $-1.39B | $-60.94B | $-41.71B | $-31.84B | $-31.14B | $-16.11B | $-22.73B | $-27.40B | $-23.64B | $-24.01B | $-22.45B | $48.94B | $-15.70B | $-20.36B | $-7.52B | $1.22B | $-42.52B |
| Debt Repayment | $86.07B | $-161.12B | $149.92B | $-74.87B | $44.25B | $1.19B | $45.65B | $-40.59B | $-170.00M | $-174.00M | $-66.06B | $41.53B | $-82.27B | $-204.00M | $-81.48B | $-70.11B | $12.09B | $98.65B | $-106.04B | $-10.81B |
| Common Stock Issued | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Common Stock Repurchased | $- | $-1.00M | $- | $-1.00M | $- | $- | $- | $-1.00M | $-1.00M | $- | $-1.00M | $- | $- | $- | $-1.00M | $- | $- | $- | $-1.00M | $- |
| Dividends Paid | $-4.75B | $-172.72B | $-367.00M | $-166.47B | $-5.03B | $-195.46B | $-299.00M | $-132.82B | $-3.81B | $-129.25B | $-318.00M | $-115.03B | $-4.77B | $-131.82B | $-381.00M | $-136.22B | $-1.76B | $-134.78B | $-221.00M | $-136.33B |
| Other Financing Activities | $-7.57B | $-7.41B | $-6.31B | $-9.10B | $-6.13B | $-2.12B | $5.84B | $-25.81B | $-37.40B | $12.66B | $4.58B | $-5.16B | $1.80B | $4.57B | $-7.39B | $23.15B | $-4.22B | $5.03B | $-4.16B | $27.77B |
| Net Cash Used Provided by Financing Activities | $73.76B | $-341.25B | $143.25B | $-250.44B | $33.09B | $-196.40B | $51.19B | $-199.21B | $-41.39B | $-116.77B | $-61.80B | $-78.65B | $-85.23B | $-127.45B | $-89.25B | $-183.18B | $6.12B | $-31.10B | $-110.42B | $-119.36B |
| Effect of Forex Changes on Cash | $49.79B | $33.83B | $-26.57B | $10.08B | $38.72B | $-19.29B | $-71.10B | $26.68B | $79.73B | $34.04B | $10.30B | $-1.82B | $3.12B | $23.01B | $-650.00M | $-22.26B | $-7.65B | $-15.54B | $2.05B | $-1.43B |
| Net Change in Cash | $320.89B | $-273.26B | $171.16B | $41.82B | $162.07B | $-201.73B | $88.42B | $29.77B | $93.44B | $-66.47B | $91.08B | $149.95B | $56.40B | $-114.54B | $80.71B | $50.39B | $106.68B | $-56.10B | $175.48B | $-127.48B |
| Cash at End of Period | $1.09T | $766.95B | $1.04T | $869.04B | $827.22B | $665.15B | $866.88B | $778.46B | $748.70B | $655.26B | $721.73B | $630.65B | $480.71B | $424.31B | $538.84B | $458.13B | $407.74B | $301.06B | $357.16B | $181.68B |
| Cash at Beginning of Period | $766.95B | $1.04T | $869.04B | $827.22B | $665.15B | $866.88B | $778.46B | $748.70B | $655.26B | $721.73B | $630.65B | $480.71B | $424.31B | $538.84B | $458.13B | $407.74B | $301.06B | $357.16B | $181.68B | $309.16B |
| Operating Cash Flow | $198.37B | $61.83B | $76.58B | $283.57B | $151.20B | $55.66B | $140.18B | $233.44B | $71.20B | $38.98B | $169.98B | $254.06B | $162.52B | $12.35B | $121.67B | $271.52B | $128.58B | $-1.94B | $282.64B | $35.83B |
| Capital Expenditure | $-34.02B | $-28.85B | $-42.41B | $-27.87B | $-21.91B | $-29.03B | $-34.69B | $-24.10B | $-21.00B | $-19.62B | $-30.40B | $-25.63B | $-24.77B | $-22.12B | $-33.17B | $-26.14B | $-20.01B | $-29.29B | $-41.72B | $-31.35B |
| Free Cash Flow | $164.36B | $32.98B | $34.17B | $255.71B | $129.29B | $26.64B | $105.49B | $209.34B | $50.20B | $19.36B | $139.57B | $228.43B | $137.75B | $-9.76B | $88.50B | $245.38B | $108.56B | $-31.23B | $240.92B | $4.48B |
Japan Tobacco Dividends
Explore Japan Tobacco's dividend history, including dividend yield, payout ratio, and historical payments.
Dividend Yield
4.83%
Dividend Payout Ratio
75.46%
Dividend Paid & Capex Coverage Ratio
1.32x
Japan Tobacco Dividend History
| Dividend | Adjusted Dividend | Date | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|
| $0.67881 | $0.67881 | June 27, 2025 | June 30, 2025 | September 01, 2025 | |
| $0.6143 | $0.6143 | December 27, 2024 | December 31, 2024 | March 27, 2025 | |
| $0.60324 | $0.60324 | June 27, 2024 | June 30, 2024 | September 04, 2024 | |
| $0.664 | $0.664 | December 28, 2023 | December 31, 2023 | March 25, 2024 | |
| $0.651 | $0.651 | June 29, 2023 | June 30, 2023 | September 01, 2023 | |
| $0.841 | $0.841 | December 29, 2022 | December 31, 2022 | March 27, 2023 | |
| $0.551 | $0.551 | June 29, 2022 | June 30, 2022 | September 01, 2022 | |
| $0.653 | $0.653 | December 29, 2021 | December 31, 2021 | March 24, 2022 | |
| $0.58821 | $0.58821 | June 29, 2021 | June 30, 2021 | September 01, 2021 | |
| $0.742 | $0.742 | December 29, 2020 | December 31, 2020 | March 25, 2021 | |
| $0.718 | $0.718 | June 29, 2020 | June 30, 2020 | September 01, 2020 | |
| $0.702 | $0.702 | December 27, 2019 | December 31, 2019 | March 23, 2020 | |
| $0.718 | $0.718 | June 26, 2019 | June 30, 2019 | September 02, 2019 | |
| $0.67981 | $0.67981 | December 26, 2018 | December 31, 2018 | March 22, 2019 | |
| $0.681 | $0.681 | June 27, 2018 | June 30, 2018 | September 03, 2018 | |
| $0.61783 | $0.61783 | December 27, 2017 | December 31, 2017 | March 28, 2018 | |
| $0.623 | $0.623 | June 28, 2017 | June 30, 2017 | September 01, 2017 | |
| $0.545 | $0.545 | December 28, 2016 | |||
| $0.627 | $0.627 | June 28, 2016 | |||
| $0.532 | $0.532 | December 28, 2015 |
Japan Tobacco News
Read the latest news about Japan Tobacco, including recent articles, headlines, and updates.
Japan Tobacco: Enjoy The Income While Waiting For Growth
Japan Tobacco offers a high 5% dividend yield, ideal for income-focused investors, despite inconsistent annual dividend growth. The stock has appreciated by 7% annually over five years, with total returns of 12% including dividends. Though no growth is expected this year, future dividend growth is expected as the company aims for high single-digit earnings growth.
Japan Tobacco Inc. (JAPAY) Full Year 2024 Earnings Call Transcript
Japan Tobacco Inc. (OTCPK:JAPAY) Q4 2024 Earnings Conference Call February 14, 2025 3:00 AM ET Company Participants Masamichi Terabatake - Group President and Chief Executive Officer Eddy Pirard - President and Chief Executive Officer of JTI Hiromasa Furukawa - Group Chief Financial Officer Vassilis Vovos - Chief Financial Officer of JTI Stefan Fitz - Chief Commercial Officer of JTI Conference Call Participants Hiroshi Saji - Mizuho Securities Satoshi Fujiwara - JP Morgan Securities Operator Thank you for participating in the Investor Meeting for 2024 Full Year Results at Japan Tobacco Inc. today despite of your busy schedule. Since it is the scheduled time, allow us to get started.
Japan Tobacco: Look Beyond In-Line Results And Consider Its Favorable Prospects (Rating Upgrade)
I upgrade Japan Tobacco from Hold to Buy, after considering its satisfactory 2024 performance and its positive outlook. JAPAF's 2024 results met expectations with an 8% increase in both its topline and operating income. Price hikes for Camel and WITH brands should boost FY25 earnings, supported by JAPAF's dominant 43% market share in Japan.
Japan Tobacco: The Vector Group Acquisition Impact
Japan Tobacco Inc.'s YTD gains are unsurprising, given its muted profit outlook, high market multiples, and lower dividend yield compared to peers even towards the start of the year. Its recent acquisition of Vector Group raises concerns further about Japan Tobacco's future sustainability as it focuses more on traditional tobacco than next-generation products. The acquisition's cost can also significantly impact earnings, raising the forward P/E ratio and potentially impacting dividends.
Japan Tobacco: It's All About The Yen (Rating Downgrade)
JAPAY's Q2 2024 top line grew by +14.0% YoY and exceeded the consensus projection by +4.6%, thanks to the weakening of the Japanese yen. But it is likely that the Japanese yen could strengthen going forward, and this means that Japan Tobacco's 2H and FY 2024 results are at risk of missing expectations. I lower my rating for JAPAY to a Hold in view of the potential yen appreciation headwind.
Japan Tobacco Inc. (JAPAF) Q3 2023 Earnings Call Transcript
Japan Tobacco Inc. (OTCPK:JAPAF) Q3 2023 Earnings Conference Call October 31, 2023 4:00 AM ET Company Participants Hiromasa Furukawa - CFO Conference Call Participants Hiroshi Saji - Mizuho Securities Satoshi Fujiwara - Nomura Securities Makoto Morita - Daiwa Securities Haruka Miyake - Morgan Stanley MUFG Takashi Miyazaki - Goldman Sachs Securities Unidentified Company Representative Thank you for participating in the Investor Meeting for Q3 2023 Results at Japan Tobacco Inc. today. Before we start the meeting, I would like to ask you to make sure that your display name is accurate.
Japan Tobacco: Accelerating Growth Justifies A Higher Valuation
Japan Tobacco faces challenges due to regulations and growing awareness of health risks, but the tobacco market continues to grow. New Zealand plans to implement a lifetime ban on tobacco purchasing for young people, but it is unlikely to have a significant effect on global tobacco revenue. Japan Tobacco is undervalued compared to some of its peers, and its growth initiatives and potential share buybacks could boost earnings and dividends.
Japan Tobacco Inc. (JAPAF) Q2 2023 Earnings Call Transcript
Japan Tobacco Inc. (OTCPK:JAPAF) Q2 2023 Earnings Conference Call July 31, 2023 4:00 AM ET Company Participants Nobuya Kato - Chief Financial Officer Koji Shimayoshi - JTI Deputy Chief Executive Officer Conference Call Participants Haruka Miyake - Morgan Stanley Hiroshi Saji - Mizuho Securities Makoto Morita - Daiwa Securities Naomi Takagi - SMBC Nikko Securities Nobuya Kato I am Nobuya Kato, CFO of the JT Group. Thank you for joining us today for the JT Group's Financial Results Briefing for the Second Quarter of Fiscal Year 2023.
E-cig startup Juul is talking to Philip Morris, Altria, and Japan Tobacco about its future, WSJ reports. Here's a rundown of the startup's rise and fall.
Juul rebranded three times, sold assets, and attracted nontraditional investors. Now, it's reportedly in partnership talks with big tobacco companies.
Japan Tobacco Inc. (JAPAF) Q1 2023 Earnings Call Transcript
Japan Tobacco Inc. (OTCPK:JAPAF) Q1 2023 Earnings Conference Call May 2, 2023 4:00 AM ET Company Participants Nobuya Kato - Chief Financial Officer Koji Shimayoshi - JTI, Deputy Chief Executive Officer Conference Call Participants Hiroshi Saji - Mizuho Securities Satoshi Fujiwara - Nomura Securities Makoto Morita - Daiwa Securities Tomonobu Tsunoyama - Mitsubishi UFJ Morgan Stanley Securities Haruka Miyake - Morgan Stanley MUFG Securities Naomi Takagi - SMBC Nikko Securities Inc Nobuya Kato I am Nobuya Kato, Chief Financial Officer of the JT Group. Thank you for joining us today for JT Group's 2023 First Quarter Earnings Briefing.
If I Could Only Buy 2 Dividend Stocks In April 2023
In today's article, I will introduce you to my two top dividend picks of the month, which I currently consider attractive due to various factors. Both companies have strong financial health, possess important competitive advantages and their valuation is currently attractive.
Japan Tobacco Inc. (JAPAF) Q4 2022 Earnings Call Transcript
Japan Tobacco Inc. (OTCPK:JAPAF) Q4 2022 Earnings Conference Call February 15, 2023 4:00 AM ET Company Participants Masamichi Terabatake - Chief Executive Officer Eddy Pirard - Chief Executive Officer of JT International Nobuya Kato - Chief Financial Officer Vassilis Vovos - Chief Financial Officer of JT International Conference Call Participants Makoto Morita - Daiwa Securities Nobuyoshi Miura - Citigroup Hiroshi Saji - Mizuho Securities Satoshi Fujiwara - Nomura Securities Naomi Takagi - SMBC Nikko Securities Haruka Miyake - Morgan Stanley MUFG Securities Operator Thank you for participating in the meeting for 2022 Full Year Results at Japan Tobacco Inc. today. It is time, so we would like to start.
Japan Tobacco Inc. (JAPAF) Q3 2022 Earnings Call Transcript
Japan Tobacco Inc. (OTCPK:JAPAF) Q3 2022 Earnings Conference Call October 31, 2022 4:00 AM ET Company Participants Nobuya Kato - Chief Financial Officer Koji Shimayoshi - Executive Vice President and Deputy Chief Executive Officer Conference Call Participants Nobuyoshi Miura - Citigroup Global Market Japan Inc Hiroshi Saji - Mizuho Securities Makoto Morita - Daiwa Securities Haruka Miyake - Morgan Stanley MUFG Securities Nobuya Kato I am Nobuya Kato, Chief Financial Officer of the JT Group. Thank you for joining us today for the JT Group's 2022 Third Quarter Earnings Briefing.
Japan Tobacco Inc. (JAPAF) Management on Q2 2022 Results - Earnings Call Transcript
Japan Tobacco Inc. (OTCPK:JAPAF) Q2 2022 Earnings Conference Call July 29, 2022 5:00 AM ET Company Participants Nobuya Kato - CFO Koji Shimayoshi - Deputy Chief Executive Officer Conference Call Participants Nobuyoshi Miura - Citigroup Global Markets Japan Hiroshi Saji - Mizuho Securities Makoto Morita - Daiwa Securities Haruka Miyake - Morgan Stanley MUFG Securities Naomi Takagi - SMBC Nikko Securities Nobuya Kato I am Nobuya Kato, Chief Financial Officer of JT Group. Thank you for joining us for the JT Group's 2022 First Half Financial Results Briefing.
Japan Tobacco: Russia Exit In The Price But 6% Dividend Yield Not Attractive Enough
We believe Japan Tobacco's exit from the Russian market will be a neutral event for the shares. The longer-term outlook for earnings is flat to falling, but this may be enough to deliver a sustainable dividend yield of 6%.
Japan Tobacco Inc. (JAPAF) Management on Q1 2022 Results - Earnings Call Transcript
Japan Tobacco Inc. (OTCPK:JAPAF) Q1 2022 Results Conference Call April 28, 2022 4:00 AM ET Company Participants Nobuya Kato - Chief Financial Officer Koji Shimayoshi - Deputy Chief Executive Officer Conference Call Participants Nobuyoshi Miura - Citigroup Global Markets Japan Satoshi Fujiwara - Nomura Securities Hiroshi Saji - Mizuho Securities Makoto Morita - Daiwa Securities Ami Yoshida - JPMorgan Securities Naomi Takagi - SMBC Nikko Securities Keiko Yamaguchi - Goldman Sachs Nobuya Kato I am Nobuya Kato, Chief Financial Officer of the JT Group. Thank you for joining us to the JT Group 2022 First Quarter Financial Result Briefing.
Uniqlo operator, Japan Tobacco to suspend Russia operations in U-turn
Uniqlo owner Fast Retailing Co and Japan Tobacco Inc on Thursday said they would suspend operations in Russia, in a U-turn by the Japanese consumer giants which had indicated they would stay in the market after Moscow's invasion of Ukraine.
Similar Companies
Related Metrics
Explore detailed financial metrics and analysis for JAPAF.